A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

Clinical trial NCT07209111 · RECRUITING

Trial details

NCT number: NCT07209111
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasm Malignant

Start date: 2025-12-04
Primary completion: 2032-04-09
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.